A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support
Recruiting
N/A
Interventional Study
Cardiogenic Shock
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 430 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
REMAP ECMO is a registry based platform in which multiple response adaptive randomized clinical trials (trial domains) will be embedded. These trial domains will, in a perpetual way, study the effects of a range of patient management strategies which aim to improve VA ECMO weaning success. A first trial domain will address the effects of left ventricular (LV) unloading through intra-aortic balloon…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria for the registry backbone:
* Having received ECMO support for severe circulatory and/or respiratory insufficiency
Inclusion Criteria for the LV unloading trial domain (VA ECMO + IABP vs VA ECMO alone):
* Cardiogenic shock
* Having received VA ECMO support for severe circulatory…
Contacts